We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-4.64%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$11.8B
AUM Growth
+$1.34B
Cap. Flow
+$2.18B
Cap. Flow %
18.39%
Top 10 Hldgs %
3.51%
Holding
4,052
New
613
Increased
1,643
Reduced
1,246
Closed
518

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$34.6M
2
WDAY icon
Workday
WDAY
+$33.5M
3
FRC
First Republic Bank
FRC
+$31.8M
4
ZTS icon
Zoetis
ZTS
+$31.3M
5
SYF icon
Synchrony
SYF
+$31M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$35.7M
2
HON icon
Honeywell
HON
+$31.7M
3
IP icon
International Paper
IP
+$30.5M
4
ADM icon
Archer Daniels Midland
ADM
+$23.8M
5
EMR icon
Emerson Electric
EMR
+$22.5M

Sector Composition

Rank Sector Weight
1 Technology 18.12%
2 Financials 17.75%
3 Healthcare 12.17%
4 Consumer Discretionary 11.8%
5 Industrials 11.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LOKM
3201
DELISTED
Live Oak Mobility Acquisition Corp.
LOKM
$118K ﹤0.01%
+12,000
New +$117K
PRTK
3202
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$116K ﹤0.01%
39,187
+26,661
+213% +$100K
AHRNW
3203
DELISTED
Ahren Acquisition Corp Warrants
AHRNW
$116K ﹤0.01%
+353,024
New +$111K
GTE icon
3204
Gran Tierra Energy
GTE
$323M
$114K ﹤0.01%
+7,252
New +$89K
RNAC icon
3205
Cartesian Therapeutics
RNAC
$260M
$114K ﹤0.01%
3,085
-1,152
-27% -$72.1K
TUSK icon
3206
Mammoth Energy Services
TUSK
$167M
$114K ﹤0.01%
+53,656
New +$97.4K
ZLSWU
3207
DELISTED
Zalatoris II Acquisition Corp Unit
ZLSWU
$114K ﹤0.01%
11,650
-20,200
-63% -$198K
AKRO
3208
DELISTED
Akero Therapeutics
AKRO
$113K ﹤0.01%
7,966
+6,219
+356% +$109K
PBYI icon
3209
Puma Biotechnology
PBYI
$455M
$112K ﹤0.01%
38,806
-6,061
-14% -$15.7K
VWE
3210
DELISTED
Vintage Wine Estates, Inc. Common Stock
VWE
$112K ﹤0.01%
11,376
-1,573
-12% -$14K
KIIIU
3211
DELISTED
Kismet Acquisition Three Corp. Unit
KIIIU
$112K ﹤0.01%
+11,400
New +$112K
FOLD
3212
DELISTED
Amicus Therapeutics
FOLD
$111K ﹤0.01%
11,712
-131,148
-92% -$1.23M
USER
3213
DELISTED
UserTesting, Inc.
USER
$111K ﹤0.01%
10,403
-39,480
-79% -$328K
CRNX icon
3214
Crinetics Pharmaceuticals
CRNX
$8.94B
$109K ﹤0.01%
4,975
+3,348
+206% +$67.8K
KLXE icon
3215
KLX Energy Services
KLXE
$31.4M
$109K ﹤0.01%
+21,053
New +$128K
BYRN icon
3216
Byrna Technologies
BYRN
$104M
$108K ﹤0.01%
13,210
-1,084
-8% -$11K
CURV icon
3217
Torrid Holdings
CURV
$247M
$108K ﹤0.01%
+17,816
New +$152K
LFCR icon
3218
Lifecore Biomedical
LFCR
$181M
$108K ﹤0.01%
+9,323
New +$104K
BHACW
3219
DELISTED
Focus Impact BH3 Acquisition Company Warrants
BHACW
$108K ﹤0.01%
+239,755
New +$107K
WEJO
3220
DELISTED
Wejo Group Limited Common Shares
WEJO
$108K ﹤0.01%
+26,853
New +$116K
STTK icon
3221
Shattuck Labs
STTK
$686M
$107K ﹤0.01%
25,004
-14,811
-37% -$84K
WTI icon
3222
W&T Offshore
WTI
$578M
$107K ﹤0.01%
28,065
-257,118
-90% -$1.13M
TCOA.WS
3223
DELISTED
Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
TCOA.WS
$107K ﹤0.01%
+346,120
New +$132K
BLNG
3224
DELISTED
Belong Acquisition Corp. Class A Common Stock
BLNG
$107K ﹤0.01%
+10,965
New +$107K
EXK
3225
Endeavour Silver
EXK
$3.08B
$106K ﹤0.01%
22,876
-38,884
-63% -$169K

Similar funds

Cubist Systematic Strategies's Q1 2022 Portfolio in Review

As of Q1 2022, Cubist Systematic Strategies held 4,052 positions worth $11.8B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

Cubist Systematic Strategies deployed $2.18B of net new capital in Q1 2022, opening 613 new positions and adding to 1,643 existing holdings. Its largest new stake was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Medtronic, an estimated $35.7M trimmed.

  • Cubist Systematic Strategies's largest Q1 2022 buy was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
  • Cubist Systematic Strategies added most to Abbott in Q1 2022, an estimated $34.6M increase.
  • Cubist Systematic Strategies's biggest Q1 2022 reduction was Medtronic, cutting an estimated $35.7M.
  • Cubist Systematic Strategies fully exited Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant in Q1 2022, selling an estimated $20.6M.
  • Cubist Systematic Strategies's ten largest holdings make up 3.5% of its $11.8B portfolio in Q1 2022.
  • Cubist Systematic Strategies opened 613 new positions and closed 518 in Q1 2022.
  • Cubist Systematic Strategies's portfolio value rose 13% quarter-over-quarter to $11.8B.

Based on Cubist Systematic Strategies's 13F filing for Q1 2022, filed 16 May 2022.